A detailed history of Headinvest, LLC transactions in Novartis Ag stock. As of the latest transaction made, Headinvest, LLC holds 17,851 shares of NVS stock, worth $1.76 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
17,851
Previous 17,978 0.71%
Holding current value
$1.76 Million
Previous $1.91 Million 7.32%
% of portfolio
0.39%
Previous 0.39%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$106.13 - $120.89 $13,478 - $15,353
-127 Reduced 0.71%
17,851 $2.05 Million
Q1 2024

Aug 14, 2024

SELL
$95.27 - $108.47 $3,524 - $4,013
-37 Reduced 0.21%
17,978 $1.74 Million
Q4 2023

Feb 12, 2024

SELL
$92.27 - $101.54 $8,119 - $8,935
-88 Reduced 0.49%
18,015 $1.82 Million
Q2 2023

Aug 23, 2023

SELL
$92.52 - $104.91 $50,238 - $56,966
-543 Reduced 2.91%
18,103 $1.83 Million
Q1 2023

May 17, 2023

SELL
$80.03 - $92.81 $9,843 - $11,415
-123 Reduced 0.66%
18,646 $1.72 Million
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $14,807 - $18,133
-196 Reduced 1.03%
18,769 $1.7 Million
Q3 2022

Dec 28, 2022

SELL
$74.61 - $87.26 $25,740 - $30,104
-345 Reduced 1.79%
18,965 $1.44 Million
Q2 2022

Aug 12, 2022

BUY
$80.52 - $93.75 $91,390 - $106,406
1,135 Added 6.24%
19,310 $1.63 Million
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $16,742 - $18,939
209 Added 1.16%
18,175 $1.6 Million
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $234,318 - $259,102
2,940 Added 19.57%
17,966 $1.57 Million
Q3 2021

Nov 16, 2021

SELL
$81.78 - $95.14 $5,152 - $5,993
-63 Reduced 0.42%
15,026 $1.23 Million
Q2 2021

Aug 30, 2021

BUY
$85.24 - $94.15 $16,962 - $18,735
199 Added 1.34%
15,089 $1.38 Million
Q1 2021

May 13, 2021

BUY
$83.5 - $98.47 $170,173 - $200,681
2,038 Added 15.86%
14,890 $1.27 Million
Q4 2020

Feb 16, 2021

BUY
$78.07 - $94.43 $143,961 - $174,128
1,844 Added 14.35%
14,696 $1.39 Million
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $143,961 - $174,128
-1,844 Reduced 12.55%
12,852 $1.12 Million
Q3 2020

Nov 24, 2020

SELL
$82.14 - $91.0 $8,214 - $9,100
-100 Reduced 0.77%
12,852 $1.12 Million
Q2 2020

Aug 12, 2020

SELL
$80.93 - $91.1 $485 - $546
-6 Reduced 0.05%
12,952 $1.13 Million
Q1 2020

May 12, 2020

SELL
$70.67 - $99.01 $56,818 - $79,604
-804 Reduced 5.84%
12,958 $1.07 Million
Q1 2020

May 11, 2020

BUY
$70.67 - $99.01 $71,376 - $100,000
1,010 Added 7.92%
13,762 $1.13 Million
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $12,652 - $14,305
-150 Reduced 1.16%
12,752 $1.21 Million
Q3 2019

Nov 21, 2019

SELL
$85.54 - $94.26 $73,564 - $81,063
-860 Reduced 6.25%
12,902 $1.12 Million
Q1 2019

May 15, 2019

SELL
$75.32 - $86.15 $1.13 Million - $1.29 Million
-14,984 Reduced 52.13%
13,762 $1.32 Million
Q4 2018

Feb 22, 2019

BUY
$73.66 - $82.02 $1.06 Million - $1.18 Million
14,373 Added 100.0%
28,746 $2.47 Million
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $18,408 - $21,293
275 Added 1.95%
14,373 $1.24 Million
Q2 2018

Aug 09, 2018

BUY
$64.91 - $73.36 $6,036 - $6,822
93 Added 0.66%
14,098 $1.07 Million
Q1 2018

Apr 09, 2018

SELL
$70.39 - $84.15 $21,117 - $25,245
-300 Reduced 2.1%
14,005 $1.13 Million
Q4 2017

Jan 30, 2018

SELL
$72.33 - $77.64 $12,296 - $13,198
-170 Reduced 1.17%
14,305 $1.2 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $1.07 Million - $1.12 Million
14,475
14,475 $1.2 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Headinvest, LLC Portfolio

Follow Headinvest, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headinvest, LLC with notifications on news.